Browsing ACHUCARRO by Author "Rodríguez-Antigüedad Zarranz, Alfredo"

Now showing items 1-2 of 2

    • Thumbnail

      Effects of FTY720 on brain neurogenic niches in vitro and after kainic acid-induced injury 

      Cipriani, Raffaela ORCID; Chara Ventura, Juan Carlos; Rodríguez-Antigüedad Zarranz, Alfredo; Matute Almau, Carlos José (Biomed Central, 2017-07-24)
      Background: FTY720 (fingolimod, Gilenya (TM)) is an oral, blood-brain barrier (BBB)-passing drug approved as immunomodulatory treatment for relapsing-remitting form of the multiple sclerosis (MS). In addition, FTY720 exerts ...
    • Thumbnail

      FTY720 attenuates excitotoxicity and neuroinflammation 

      Cipriani, Raffaela ORCID; Chara Ventura, Juan Carlos; Rodríguez-Antigüedad Zarranz, Alfredo; Matute Almau, Carlos José (BioMed Central, 2015-05-08)
      Background: FTY720 (fingolimod, Gilenya(TM)), a structural analog of sphingosine-1-phosphate (S1P), is the first oral drug approved for treatment the relapsing-remitting form of multiple sclerosis (MS), and its efficacy ...